Chu, Gordon ;
Seelig, Jaap ;
Trinks-Roerdink, Emmy M...
Chu , G , Seelig , J , Trinks-Roerdink , E M , van Alem , A P , Alings , M , van den Bemt , B , Boersma , L V A , Brouwer , M A , Cannegieter , S C , ten Cate , H , Kirchhof , C J H J , Crijns , H J G M , van Dijk , E J , Elvan , A , van Gelder , I C , de Groot , J R , den Hartog , F R , de Jong , J S S G , de Jong , S , Klok , F A , Lenderink , T , Luermans , J G , Meeder , J G , Pisters , R , Polak , P , Rienstra , M , Smeets , F , Tahapary , G J M , Theunissen , L , Tieleman , R G , Trines , S A , van der Voort , P , Geersing , G-J , Rutten , F H , Hemels , M E & Huisman , M 2020 , ' Design and rationale of DUTCH-AF : a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation ' , BMJ Open , vol. 10 , no. 8 , 036220 . https://doi.org/10.1136/bmjopen-2019-036220.
,
2020